Lithium citrate

柠檬酸锂

Report date: 2022/06/04 20:00:28
NME

Base Information

Drug NameLithium citrate
Drug Alias NameLithonate
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeurons modulators
TargetsNot applicable
Therapy Area/IndicationsBipolar Disorder
Global Approved IndicationsBipolar Disorder
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1980/12/23
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHikma Pharmaceuticals Plc
Active IndicationsN/A
Inactive IndicationsBipolar Disorder

Other Information

ATC CodeN05AN01